Role of Quinones in Toxicology
The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Abstract
Quinones represent a class of toxicological intermediates which can create a variety of hazardous effects in vivo, including acute cytotoxicity, immunotoxicity, and carcinogenesis. The mechanisms by which quinones cause these effects can be quite complex. Quinones are Michael acceptors, and cellular damage can occur through alkylation of crucial cellular proteins and/or DNA. Alternatively, quinones are highly redox active molecules which can redox cycle with their semiquinone radicals, leading to formation of reactive oxygen species (ROS), including superoxide, hydrogen peroxide, and ultimately the hydroxyl radical. Production of ROS can cause severe oxidative stress within cells through the formation of oxidized cellular macromolecules, including lipids, proteins, and DNA. Formation of oxidatively damaged bases such as 8-oxodeoxyguanosine has been associated with aging and carcinogenesis. Furthermore, ROS can activate a number of signaling pathways, including protein kinase C and RAS. This review explores the varied cytotoxic effects of quinones using specific examples, including quinones produced from benzene, polycyclic aromatic hydrocarbons, estrogens, and catecholamines. The evidence strongly suggests that the numerous mechanisms of quinone toxicity (i.e., alkylation vs oxidative stress) can be correlated with the known pathology of the parent compound(s).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While it is not that easy to disentangle the complex reactions of ROSs with biomolecules [43,1055], at least the following appear to be a result of reactions involving OH• [2294,2295]: 8-oxo-2'-deoxyguanosine (oxo8dG) [98,2296,2297], 8-oxo-7,8- dihydro-2'-deoxyguanosine [90,92] and thymine glycol [92,2294].”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [2296]
Citations
Cites
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322401 · Cited by 1,487
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383
Lipid peroxidation—DNA damage by malondialdehyde
Marnett, L. J. (1999) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(99)00010-x · Cited by 1,304
Gelboin, H. V. (1980) · Physiological Reviews · doi:10.1152/physrev.1980.60.4.1107 · Cited by 1,280
Lipid hydroperoxide generation, turnover, and effector action in biological systems
Girotti, A. W. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32182-9 · Cited by 1,200
Postmenopausal Hormone Therapy and Mortality
Grodstein, F., Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., Joffe, M., Rosner, B., Fuchs, C., Hankinson, S. E., Hunter, D. J., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706193362501 · Cited by 1,184
Casarett & Doull's Toxicology: The Basic Science of Poisons
Klaassen, C. D. (1998) · Cited by 1,179
Molecular mechanisms of quinone cytotoxicity
O'Brien, P. J. (1991) · Chemico-Biological Interactions · doi:10.1016/0009-2797(91)90029-7 · Cited by 1,029
Research works printed but not linked: 203
- Miller E. C., 1978, Some current perspectives on chemical carcinogenesis in humans and experimental animals: presidential address. Cancer Res. 38, 1479−1496
- Cavalieri E. L., 1995, Central role of radical cations in metabolic activation of polycyclic aromatic hydrocarbons. Xenobiotica 25, 677−688
- Marnett L. J., 1995, Biochem. Soc. Symp. 61
- Aust S. D., 1993, Contemporary issues in toxicology: Free radicals in toxicology. Toxicol. Appl. Pharmacol. 120, 168−178
- Palmer H. J., 1997, Nutr. Rev., 55
- Shigenaga M. K., 1991, Assays for 8-hydroxy-2‘-deoxyguanosine: A biomarker of in vivo oxidative DNA damage. Free Radical Biol. Med. 10, 211−216
- Schlosser M. J., 1989, Metabolic activation of hydroquinone by macrophage peroxidase. Chem.-Biol. Interact. 72, 191−207
- Robertson M. L., 1991, Two benzene metabolites, catechol and hydroquinone, produce a synergistic induction of micronuclei and toxicity in cultured human lymphocytes. Mutat. Res. 249, 201−209
- Levay G., 1991, Detection of DNA adducts in HL-60 cells treated with hyroquinone and p-benzoquinone by 32P-postlabeling. Carcinogenesis 12, 1181−1186
- Bolton J. L., 1998, Role of quinoids in estrogen carcinogenesis. Chem. Res. Toxicol. 11, 1113−1127
- Monks T. J., 1997, Biological reactivity of polyphenolic glutathione conjugates. Chem. Res. Toxicol. 10, 1296−1313
- Wallace L., 1996, Environmental exposure to benzene: An update. Environ. Health Perspect. 104 (Suppl. 6), 1129−1136
- Greenburg L., 1996, Results of medical examination and clinical tests made to discover early signs of benzol poisoning in exposed workers. Environ. Health Perspect. 104 (Suppl. 6), 1129−1136
- Aksoy M., 1971, Br. J. Ind. Med., 28
- Infante P. F., 1977, Lancet, 2, 78
- Fiserova-Beregerova V., 1995, Advances in occupational medicine and rehabilitation: Update on benzene
- Snyder R., 1996, An overview of benzene metabolism. Environ. Health Perspect. 104 (Suppl. 6), 1165−1171
- Seaton M. J., 1994, Benzene metabolism by human liver microsomes in relation to cytochrome P450 2E1 activity. Carcinogenesis 15, 1799−1806
- Valentine J. L., 1996, Reduction in benzene metabolism and toxicity in mice that lack CYP2E1 expression. Toxicol. Appl. Pharmacol. 141, 205−213
- Twerdok L. E., 1992, Induction of quinone reductase and glutathione in bone marrow stromal cells by 1,2-dithiole-3-thione: efect on hydroquinone-induced cytotoxicity. Toxicol. Appl. Pharmacol. 112, 273−281
- Creek M. R., 1997, Tissue distribution and macromolecular binding of extremely low doses of [14C]-benzene in B6C3F1 mice. Carcinogenesis 18, 2421−2427
- Smith M. T., 1996, The mechanism of benzene-induced leukemia: A hypothesis and speculation on the causes of leukemia. Environ. Health Perspec. 104 (Suppl. 6), 1219−1225
- He H., 1999, Phorbol ester-induced mononuclear cell differentiation is blocked by the mitogen-activated protein kinase (MEK) inhibitor PD98059. Cell Growth Differ. 10, 307−315
- Li Y., 1999, Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen production. Biochem. Biophys. Res. Commun. 253, 295−299
- Li Y., 1993, DNA damage resulting from the oxidation of hydroquinone by copper: role for a Cu(II)/Cu(I) redox cycle and reactive oxygen generation. Carcinogenesis 14, 1303−1311
- Rothman N., 1997, Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C→T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res. 57, 2839−2842
- Morgan J. L., 1999, Proc. Natl. Acad. Sci. U.S.A. 96
- Smith M. T., 1999, Proc. Natl. Acad. Sci. U.S.A. 96
- Trush M. A., 1996, Analysis of target cell susceptibility as a basis for the development of a chemoprotective strategy against benzene-induced hematotoxicities. Environ. Health Perspect. 104 (Suppl. 6), 1227−1234
- Kensler T. W., 1999, Development of cancer chemopreventive agents: oltipraz as a paradigm. Chem. Res. Toxicol. 12, 113−126
- Primiano T., 1998, Identification of dithiolethione-inducible gene-1 as a leukotriene B4 12-hydroxydehydrogenase: implications for chemoprevention. Carcinogenesis 19, 999−1005
- Conney A. H., 1982, Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. Cancer Res. 42, 4875−4917
- Slaga T. J., 1977, Comparison of the tumor-initiating activities of benzo[a]pyrene arene oxides and diol-epoxides. Cancer Res. 37, 4130−4133
- Kim K. B., 1997, Cancer Lett., 113
- Leadon S. A., 1988, Proc. Natl. Acad. Sci. U.S.A. 85
- Chakravarti D., 1995, Proc. Natl. Acad. Sci. U.S.A. 92
- Denissenko M. F., 1996, Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 274, 430−432
- Sagher D., 1983, Insertion of nucleotides opposite apurinic/apyrimidinic sites in deoxyribonucleic acid during in vitro synthesis: uniqueness of adenine nucleotides. Biochemistry 22, 4518−4526
- Jez J. M., 1997, A new nomenclature for the aldo-keto reductase superfamily. Biochem. Pharmacol. 54, 639−647
- Burczynski M. E., 1999, J. Polycyclic Aromatic Compd. (in press).
- Smithgall T. E., 1988, J. Biol. Chem., 263
- Flowers-Geary L., 1995, Identification of benzo[a]pyrene-7,8-dione as an authentic metabolite of (±)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene in isolated rat hepatocytes. Carcinogenesis 16, 2707−2715
- Tsuruda L., 1999, J. Polycyclic Aromatic Compd. (in press).
- Murty V. S., 1992, Characterization of mercapturic acid and glutathionyl conjugates of benzo[a]pyrene-7,8-dione by two-dimensional NMR. Bioconjugate Chem. 3, 218−224
- Flowers-Geary L., 1993, Cytotoxicity of polycyclic aromatic hydrocarbon o-quinones in rat and human hepatoma cells. Chem. Res. Toxicol. 6, 252−260
- Flowers L., 1996, Disposition and biological activity of benzo[a]pyrene-7,8-dione. A genotoxic metabolite generated by dihydrodiol dehydrogenase. Biochemistry 35, 13664−13672
- Shou M., 1993, Reactivity of benzo[a]pyrene-7,8-dione with DNA. Evidence for the formation of deoxyguanosine adducts. Carcinogenesis 14, 475−482
- McCoull K. D., 1999, Synthesis and characterization of polycyclic aromatic hydrocarbon o-quinone depurinating N7-guanine adducts. Chem. Res. Toxicol. 12, 237−246
- Flowers L., 1997, Cu(II), Cu(I) redox cycling, and o-semiquinone anion radicals. Biochemistry 36, 8640−8648.
- Breen A. P., 1995, Reactions of oxyl radicals with DNA. Free Radical Biol. Med. 18, 1033−1077
- Cerutti P. A., 1985, Prooxidant states and tumor promotion. Science 227, 375−381
- Henderson B. E., 1988, Estrogens as a cause of human cancer: The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res. 48, 246−253
- Liehr J. G., 1990, Genotoxic effects of estrogens. Mutat. Res. 238, 269−276
- Feigelson H. S., 1996, Estrogens and breast cancer. Carcinogenesis 17, 2279−2284
- Service R. F., 1998, New role for estrogen in cancer? Science 279, 1631−1633
- Zhu B. T., 1998, Carcinogenesis, 19, 27
- Roy D., 1999, DNA damage and mutations. Mutat. Res. 424, 107−115.
- Liehr J. G., 1983, 2-Fluoroestradiol. Separation of Estrogenicity from Carcinogenicity. Mol. Pharmacol. 23, 278−281
- Li J. J., 1984, Estrogen-induced tumorigenesis in hamsters: Roles for hormonal and carcinogenic activities. Arch. Toxicol. 55, 110−118
- Vassilopoulou-Sellin R., 1993, Estrogen replacement therapy in women at increased risk for breast cancer. Breast Cancer Res. Treat. 28, 167−177
- Lupulescu A., 1995, Estrogen Use and Cancer Incidence: A Review. Cancer Invest. 13, 287−295
- Wickelgren I., 1997, Estrogen: A new weapon against Alzheimer's. Science 276, 676−677
- Henderson V. W., 1997, S27−S35.
- Paganinihill A., 1995, Estrogen replacement therapy and stroke. Prog. Cardiovasc. Dis. 38, 223−242
- Grady D., 1995, Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet. Gynecol. 85, 304−313
- Kerlan V., 1992, Nature of cytochromes P450 involved in the 2-/4-hydroxylations of estradiol in human liver microsomes. Biochem. Pharmacol. 44, 1745−1756
- Suchar L. A., 1996, Effects of phenobarbital, dexamethasone, and 3-methylcholanthrene administration on the metabolism of 17β-estradiol by liver microsomes from female rats. Endocrinology 137, 663−676
- Spink D. C., 1998, Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis 19, 291−298
- Shimada T., 1999, Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis 20, 1607−1614
- Li J. J., 1987, Fed. Proc. 46
- Li S. A., 1985, Estrogen 2- and 4-hydroxylase activity, catechol estrogen formation, and implications for estrogen carcinogenesis in the hamster kidney. Cancer Res. 45, 181−185
- Sarabia S. F., 1997, Mechanism of cytochrome P450-catalyzed aromatic hydroxylation of estrogens. Chem. Res. Toxicol. 10, 767−771
- Zhang F., 1999, The major metabolite of equilin, 4-hydroxyequilin autoxidizes to an o-quinone which isomerizes to the potent cytotoxin 4-hydroxyequilenin-o-quinone. Chem. Res. Toxicol. 12, 204−213
- Yager J. D., 1996, Annu. Rev. Pharmacol. Toxicol., 36, 10.1146/annurev.pa.36.040196.001223 · DOI · Paper page
- Iverson S. L., 1996, Bioactivation of estrone and its catechol metabolites to quinoid-glutathione conjugates in rat liver microsomes. Chem. Res. Toxicol. 9, 492−499
- Shen L., 1997, Bioreductive activation of catechol estrogen-ortho-quinones: Aromatization of the B ring in 4-hydroxyequilenin markedly alters quinoid formation and reactivity. Carcinogenesis 18, 1093−1101
- Penning T. M., 1993, Chem.-Biol. Interact., 89, 34, 10.1016/0009-2797(93)03203-7 · DOI
- Malins D. C., 1996, Proc. Natl. Acad. Sci. U.S.A. 93
- Shigenaga M. K., 1991, Assays for 8-hydroxy-2‘-deoxyguanosine: A biomarker of in vivo oxidative DNA damage. Free Radical Biol. Med. 10, 211−216
- Floyd R. A., 1990, The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis 11, 1447−1450
- Han X., 1994, 8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol. Role of free radicals in estrogen-induced carcinogenesis. Cancer Res. 54, 5515−5517
- Nutter L. M., 1994, Chem. Res. Toxicol., 7, 28
- Li J. J., 1993, Estrogen carcinogenesis in the hamster kidney: role of cytotoxicity and cell proliferation. Environ. Health Perspect. 5, 259−264
- Banerjee S. K., 1994, Induction of chromosome aberrations in Syrian hamster renal cortical cells by various estrogens. Mutat. Res. 311, 191−197
- Chen Y., 1998, The equine estrogen metabolite 4-hydroxyequilenin causes DNA single strand breaks and oxidation of DNA bases in vitro. Chem. Res. Toxicol. 11, 1105−1111
- Chen Y., 2000, GADD153 expression and apoptosis in breast cancer cell lines. Chem. Res. Toxicol. (submitted for publication).
- Han X., 1995, Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: correlation of DNA damage by free radicals with metabolic activation to quinones. Carcinogenesis 16, 2571−2574
- Liehr J. G., 1986, Proc. Natl. Acad. Sci. U.S.A. 83
- Liehr J. G., 1987, Localization of estrogen-induced DNA adducts and cytochrome P450 activity at the site of renal carcinogenesis in the hamster kidney. Cancer Res. 47, 2156−2159
- Abul-Hajj Y. J., 1995, J. Am. Chem. Soc., 117
- Stack D. E., 1996, Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides. Chem. Res. Toxicol. 9, 851−859
- Loeb L. A., 1986, Annu. Rev. Genet., 20
- Cavalieri E. L., 1997, Proc. Natl. Acad. Sci. U.S.A. 94
- Shen L., 1997, J. Am. Chem. Soc., 119
- Shen L., 1998, Chem. Res. Toxicol., 11, 101
- Ricaurte G., 1985, Hallucinogenic amphetamine selectively destroys serotonin nerve terminals. Science 229, 986−988
- Commins D. L., 1987, J. Pharmacol. Exp. Ther., 241
- Henry J. A., 1992, Toxicity and deaths from 3,4-methylenedioxymethamphetamine. Lancet 340, 384−387
- Stone D. M., 1986, Eur. J. Pharmacol., 128, 48
- Stone D. M., 1987, Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat. Neuropharmacology 26, 1677−1683
- Battaglia G., 1987, J. Pharmacol. Exp. Ther., 242
- Lew R., 1996, J. Pharmacol. Exp. Ther., 276
- Bolla K. I., 1998, Memory impairmant in abstinent MDMA (“ecstasy”) users. Neurology 51, 1532−1537
- McCann U. D., 1999, Cognitive performance in (±)-3,4-methylenedioxyamphetamine (MDMA, “ecstasy”) users: a control study. Psychopharmacology 143, 147−425
- McCann U. D., 1998, Positron emission tomographic evidence of toxic effects of MDMA (“ecstasy”) on brain serotonin neurons in human beings. Lancet 352, 1433−1437
- Ricuarte G. A., 1988, Toxic effects of MDMA on central serotonergic neurons in primate: importance of route and frequency of drug administration. Brain Res. 446, 165−168
- Molliver M. E., 1986, Soc. Neurosci. Abstr., 12, 1234
- Schmidt C. J., 1988, Eur. J. Pharmacol., 156
- Paris J. M., 1992, Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA). Brain. Res. Bull. 28, 115−119
- Gollamudi R., 1989, Influence of inducers and inhibitors on the metabolism in vitro and neurochemical effects in vivo of MDMA. Neurotoxicology 10, 455−466
- McCann U. A., 1991, Major metabolites of 3,4-methylenedioxyamphetamine (MDA) do not mediate its toxic effects on brain serotonin neurons. Brain Res. 545, 279−282
- Midha K. K., 1978, α-Methyldopamine, a key intermediate in the metabolic disposition of 3,4-methylenedioxyamphetamine in vivo in dog and monkey. Drug Metab. Dispos. 6, 623−630
- Lim H. K., 1988, vivo and in vitro metabolism of 3,4-methylenedioxymethamphetamine in the rat: identification of metabolites using an ion trap detector. Chem. Res. Toxicol. 1, 370−378
- Hiramatsu M., 1990, J. Pharmacol. Exp. Ther., 254
- Patel N., 1991, Transformation of dopamine and α-methyldopamine by NG-108-15 cells: formation of thiol adducts. Chem. Res. Toxicol. 4, 421−426
- Miller R. T., 1995, Metabolism of 5-(Glutathion-S-yl)-α-methyldopamine following intracerebroventricular administration to male Sprague-Dawley rats. Chem. Res. Toxicol. 8, 634−641
- Tunek A., 1981, Toxic effects of benzene and benzene metabolites on granulopoietic stem cells and bone marrow cellularity in mice. Toxicol. Appl. Pharmacol. 59, 149−156
- Yin S. N., 1987, Br. J. Ind. Med., 44
- Snyder R., 1993, Studies on the mechanism of benzene toxicity. Environ. Health Perspect. 100, 293−306
- Bratton S. B., 1997, Identification of quinol-thioethers in bone marrow of hydroquinone/phenol-treated rats and mice and their potential role in benzene-mediated hematotoxicity. Chem. Res. Toxicol. 10, 859−865
- Thompson C. B., 1995, Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456−1462
- Moran J. L., 1996, Induction of apoptosis by benzene metabolites in HL-60 cells and CD34+ human bone marrow progenitor cells. Mol. Pharmacol. 50, 610−615
- Hazel B. A., 1996, Hydroquinone, a bioreactive metabolite of benzene, inhibits apoptosis in myeloblasts. Stem Cells 14, 730−742
- Liu B., 1997, J. Biol. Chem., 272
- Hannun Y. A., 1996, Functions of ceramide in coordinating cellular responses to stress. Science 274
- Zager R. A., 1997, Kidney Int., 52, 70
- Nicholson D. W., 1995, Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis Nature 376, 37−43
- Dobrowski R. T., 1992, J. Biol. Chem., 267
- Suzuki Y. J., 1997, Oxidants as stimulators of signal transduction. Free Radical Biol. Med. 22, 269−285
- Rajavashisth T. B., 1990, Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 344, 254−257
- Ishiguro S., 1976, Glass capillary column gas chromatographic analysis of tobacco and cellulose cigarette smoke. I. Acidic fractions. Kenkyu HokokuNippon Senbai Kosha Chuo Kenkyusho 118, 207−211
- Kari F. W., 1992, Toxicity and carcinogenicity of hydroquinone in F344/N rats and B6C3F1 mice. Food Chem. Toxicol. 30, 737−747
- Shibata M. A., 1991, Jpn. J. Cancer Res., 82
- Peters M. M., 1997, Cytotoxicity and cell proliferation induced by the nephrocarcinogen hydroquinone, and its nephrotoxic metabolite 2,3,5-tris-(glutathion-S-yl)hydroquinone. Carcinogenesis 18, 2393−2401
- Lau S. S., 2000, The nephrocarcinogenicity of a nephrotoxic metabolite of the “non-genotoxic
- Peters M. M., 1996, Metabolism of 2-tert-butylhydroquinone to S-substituted conjugates in the male Fischer 344 rat. Chem. Res. Toxicol. 9, 133−139
- Peters M. M., 1996, Glutathione conjugates of 2-tert-butylhydroquinone, metabolites of the renal tumor promoter tert-butylhydroxyanisole, are toxic to kidney and bladder. Cancer Res. 56, 1006−1011
- Tsuda H., 1984, Acta Pharmacol. Toxicol., Suppl., 2
- Ito N., 1986, Studies on antioxidants: their carcinogenic and modifying effects on chemical carcinogenesis. Food Chem. Toxicol. 24, 1071−1082
- Verhagen H., 1989, Disposition of single oral doses of butylated hydroxyansiole in man and rat. Food Chem. Toxicol. 27, 151−158
- Shibata M. A., 1991, Toxicol. Lett., 55
- Verhagen H., 1991, Butylated hydroxyanisole in perspective. Chem.-Biol. Interact. 80, 109−134
- Liehr J. G., 1990, Free radical generation of cycling estrogens. Free Radical Biol. Med. 8, 415−423
- Matthews V. S., 1947, Proc. Soc. Exp. Biol. Med. 66
- Kirkman H., 1952, J. Natl. Cancer Inst., 13
- Kirkman H., 1959, Natl. Cancer Inst. Monogr., 1, 57
- Hattori N., 1991, II, III, and IV of mitochondria in Parkinson's disease. Ann. Neurol. 30, 563−571.
- Mizuno Y., 1994, An immunohistochemical study on α-ketoglutarate dehydrogenase complex in Parkinson's disease. Ann. Neurol. 35, 204−210
- Ikebe S., 1995, Point mutations of mitochondrial genome in Parkinson's disease. Brain Res. Mol. Brain Res. 28, 281−295
- Swerdlow R. H., 1996, Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol. 40, 663−671
- Kobayashi T., 1998, Association between the gene encoding the E2 subunit of the α-ketoglutarate dehydrogenase complex and Parkinson's disease. Ann. Neurol. 43, 120−123
- Schapira A. H. V., 1996, Neurodegeneration and Neuroprotection in Parkinson's Disease
- Dexter D. T., 1989, J. Neurochem., 52
- Alam Z. I., 1997, J. Neurochem., 69
- Alam Z. I., 1997, J. Neurochem., 69
- Benzi G., 1991, Sequential damage in mitochondrial complexes by peroxidative stress. Neurochem. Res. 16, 1295−1302
- Dexter D. T., 1994, Ann. Neurol., 35, 44
- Sian J., 1994, Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36, 348−355
- Sian J., 1994, Glutathione-related enzymes in brain in Parkinson's disease. Ann. Neurol. 36, 356−361
- Seaton T. A., 1996, Mitochondrial respiratory enzyme function and superoxide dismutase activity following brain glutathione depletion in the rat. Biochem. Pharmacol. 52, 1657−1663
- Meister A., 1981, γ-Glutamyl transpeptidase. Methods Enzymol. 77, 237−253
- Mithofer K., 1992, Mitochondrial poisons cause depletion of reduced glutathione in isolated hepatocytes. Arch. Biochem. Biophys. 295, 132−136
- Khan S., 1997, Rapid and specific efflux of glutathione before hepatocyte injury induced by hypoxia. Biochem. Biophys. Res. Commun. 238, 320−322
- Reed D. J., 1995, Biochim. Biophys. Acta, 1271, 50
- Sanchez-Ramos J., 1998, Toxicity of dieldrin for dopaminergic neurons in mesencephalic cultures. Exp. Neurol. 150, 263−271
- Seidler A., 1996, Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology 46, 1275−1284
- Fleming L., 1994, Parkinson's disease and brain levels of organochlorine pesticides. Ann. Neurol. 36, 100−103
- Corrigan F. M., 1998, Diorthosubstituted polychlorinated biphenyls in caudate nucleus in Parkinson's disease. Exp. Neurol. 150, 339−342
- Le Couteur D. G., 1998, The ageing liver: drug clearance and an oxygen diffusion barrier hypothesis. Clin. Pharmacokinet. 34, 359−373
- Ho S. L., 1996, Adv. Neurol., 69, 60
- Steventon G. B., 1989, Xenobiotic metabolism in Parkinson's disease. Neurology 39, 883−887
- Armstrong M., 1992, Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet 339, 1017−1018
- Stroombergen M. C., 1999, Determination of glutathione S-transferase mu and theta polymorphisms in neurological disease. Hum. Exp. Toxicol. 18, 141−145
- De Palma G., 1998, Case-control study of interactions between genetic and environmental factors in Parkinson's disease. Lancet 352
- Bandmann O., 1997, Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease. Lancet 350, 1136−1139
- Shahi G. S., 1990, Parkinson's disease and cytochrome P450: a possible link? Med. Hypotheses 32, 277−282
- Gerlach M., 1996, J. Neural Transm., 103
- Ferraro T. N., 1986, Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutathione in the extrapyramidal system of the mouse. Neuropharmacology 25, 1071−1074
- Yong V. W., 1986, Neurosci. Lett., 63, 60
- Oishi T., 1993, Sulfhydryl drugs reduce neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse. J. Neural Transm.: Parkinson's Dis. Dementia Sect. 6, 45−52
- Ramsay R. R., 1986, Energy driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP. Life Sci. 39, 581−588
- Mizuno Y., 1987, Inhibition of mitochondrial α-ketoglutarate dehydrogenase by 1-methyl-4-phenylpyridinium ion. Biochem. Biophys. Res. Commun. 143, 971−976
- Smith T. S., 1994, eport 5, 2598−2600.
- Cao C. J., 1990, ATP-regulated neuronal catecholamine uptake: a new mechanism. Life Sci. 47, 655−667
- Han J., 1999, J. Neurochem., 73
- Dringen R., 1997, The γ-glutamyl transpeptidase inhibitor acivicin preserves glutathione released by astroglial cells in culture. Neurochem. Res. 22, 727−733
- Novelli A., 1988, Glutamate becomes neurotoxic when intracellular energy levels are reduced. Brain Res. 451, 205−212
- Zeevalk G. D., 1991, J. Pharmacol. Exp. Ther., 257
- Olney J. W., 1990, l-Cysteine, a bicarbonate-sensitive excitotoxin. Science 248, 596−599
- Lafon-Cazal M., 1993, NMDA-dependent superoxide production and neurotoxicity. Nature 364, 535−537
- Beal M. F., 1996, Neurodegeneration and Neuroprotection in Parkinson's Disease
- Beckman J. S., 1990, Proc. Natl. Acad. Sci. U.S.A. 87
- Flint D. H., 1993, J. Biol. Chem., 268
- Gutteridge J. M. C., 1996, Hydroxyl radicals, iron, oxidative stress, and neurodegeneration. Ann. N.Y. Acad. Sci. 738, 201−213
- Spencer J. P. E., 1998, J. Neurochem., 71
- Sagara J., 1993, J. Neurochem., 61
- Tate S. S., 1985, γ-Glutamyl transpeptidase from kidney. Methods Enzymol. 113, 400−437
- Zhang F., 1994, J. Med. Chem., 37
- Shen X.-M., 1996, Further insights into the influence of l-cysteine on the oxidation chemistry of dopamine: reaction pathways of potential relevance to Parkinson's disease. Chem. Res. Toxicol. 9, 751−763
- Li H., 1997, J. Neurochem., 69
200 of 203 shown
Cited by
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
Meanwell, N. A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01788 · Cited by 2,655
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
Bhattacharyya, A., Chattopadhyay, R., Mitra, S., & Crowe, S. E. (2014) · Physiological Reviews · doi:10.1152/physrev.00040.2012 · Cited by 2,484
“Chemical agents like quinones (33); heavy metals such as lead, arsenic, mercury, chromium, and cadmium; organic solvents; and pesticides are common exogenous sources of ROS (331).”
BackgroundReview on in vivo and in vitro methods evaluation of antioxidant activity
Alam, M. N., Bristi, N. J., & Rafiquzzaman, M. (2013) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2012.05.002 · Cited by 1,758
Lee, W. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021844 · Cited by 1,594
VALAVANIDIS, A., FIOTAKIS, K., & VLACHOGIANNI, T. (2008) · Journal of Environmental Science and Health, Part C · doi:10.1080/10590500802494538 · Cited by 1,491
The oxidative environment and protein damage
Davies, M. J. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.08.007 · Cited by 1,392
Induction of phase I, II and III drug metabolism/transport by xenobiotics
Xu, C., Li, C. Y.-T., & Kong, A.-N. T. (2005) · Archives of Pharmacal Research · doi:10.1007/bf02977789 · Cited by 1,279
Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: A review
Xue, W., & Warshawsky, D. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.11.006 · Cited by 895
Tebay, L. E., Robertson, H., Durant, S. T., Vitale, S. R., Penning, T. M., Dinkova-Kostova, A. T., & Hayes, J. D. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.021 · Cited by 837
“Exposure to xenobiotics that are quinone-based or give rise to quinones or quinoneimines is also a cause of oxidative stress through one-electron and two-electron redox cycling [18].”
Self-citationOxidative stress and air pollution exposure
Lodovici, M., & Bigagli, E. (2011) · Journal of Toxicology · doi:10.1155/2011/487074 · Cited by 720
Composition of Air Pollution Particles and Oxidative Stress in Cells, Tissues, and Living Systems
Ghio, A. J., Carraway, M. S., & Madden, M. C. (2012) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937404.2012.632359 · Cited by 544
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Thymoquinone: Potential cure for inflammatory disorders and cancer
Woo, C. C., Kumar, A. P., Sethi, G., & Tan, K. H. B. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.09.029 · Cited by 541
Formation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective Effects
Bolton, J. L., & Dunlap, T. (2017) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00256 · Cited by 522
Self-citationLundstedt, S., White, P. A., Lemieux, C. L., Lynes, K. D., Lambert, I. B., Öberg, L., Haglund, P., & Tysklind, M. (2007) · AMBIO: A Journal of the Human Environment · doi:10.1579/0044-7447(2007)36[475:sfatho]2.0.co;2 · Cited by 487
Li, N., Alam, J., Venkatesan, M. I., Eiguren-Fernandez, A., Schmitz, D., Di Stefano, E., Slaughter, N., Killeen, E., Wang, X., Huang, A., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3467 · Cited by 456
Indian medicinal herbs as sources of antioxidants
Ali, S. S., Kasoju, N., Luthra, A., Singh, A., Sharanabasava, H., Sahu, A., & Bora, U. (2008) · Food Research International · doi:10.1016/j.foodres.2007.10.001 · Cited by 457
Toxicity of amphetamines: an update
Carvalho, M., Carmo, H., Costa, V. M., Capela, J. P., Pontes, H., Remião, F., Carvalho, F., & Bastos, M. D. L. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0815-5 · Cited by 431
Apparent activity in high-throughput screening: origins of compound-dependent assay interference
Thorne, N., Auld, D. S., & Inglese, J. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.03.020 · Cited by 430
Understanding the human health effects of chemical mixtures.
Carpenter, D. O., Arcaro, K., & Spink, D. C. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.02110s125 · Cited by 424
Rietjens, I. M. C. M., Boersma, M. G., Haan, L. D., Spenkelink, B., Awad, H. M., Cnubben, N. H. P., van Zanden, J. J., Woude, H. V. D., Alink, G. M., & Koeman, J. H. (2002) · Environmental Toxicology and Pharmacology · doi:10.1016/s1382-6689(02)00003-0 · Cited by 406
Ch, S., & Dave, R. A. (2009) · African Journal of Microbiology Research · doi:10.5897/ajmr.9000401 · Cited by 405
Reactive oxygen species in pulmonary inflammation by ambient particulates
Tao, F., Gonzalez-Flecha, B., & Kobzik, L. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00280-6 · Cited by 392
Benigni, R., & Bossa, C. (2011) · Chemical Reviews · doi:10.1021/cr100222q · Cited by 377
Lipczynska-Kochany, E. (2018) · Chemosphere · doi:10.1016/j.chemosphere.2018.03.104 · Cited by 379
Encyclopedia of Dietary Supplements
(2010) · CRC Press eBooks · doi:10.1201/b14669 · Cited by 380
Montero-Montoya, R., López-Vargas, R., & Arellano-Aguilar, O. (2018) · Annals of Global Health · doi:10.29024/aogh.910 · Cited by 323
Kehrer, J. P., & Klotz, L.-O. (2015) · Critical Reviews in Toxicology · doi:10.3109/10408444.2015.1074159 · Cited by 339
Naphthalene?an environmental and occupational toxicant
Preuss, R., Angerer, J., & Drexler, H. (2003) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-003-0458-1 · Cited by 337
Inhibition of 15-lipoxygenases by flavonoids: structure–activity relations and mode of action
Sadik, C. D., Sies, H., & Schewe, T. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01621-0 · Cited by 338
Bandowe, B. A. M., Meusel, H., Huang, R.-J., Ho, K., Cao, J., Hoffmann, T., & Wilcke, W. (2014) · Science of The Total Environment · doi:10.1016/j.scitotenv.2013.11.108 · Cited by 336
Protein tyrosine phosphatases as potential therapeutic targets
He, R.-J., Yu, Z.-H., Zhang, R.-Y., & Zhang, Z.-Y. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.80 · Cited by 327
The Role of Body-on-a-Chip Devices in Drug and Toxicity Studies
Esch, M. B., King, T. L., & Shuler, M. L. (2011) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071910-124629 · Cited by 328
The Chemical Biology of Naphthoquinones and Its Environmental Implications
Kumagai, Y., Shinkai, Y., Miura, T., & Cho, A. K. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134517 · Cited by 332
Antioxidant Capacity Determination in Plants and Plant‐Derived Products: A Review
Pisoschi, A. M., Pop, A., Cimpeanu, C., & Predoi, G. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9130976 · Cited by 304
Understanding cancer and the anticancer activities of naphthoquinones – a review
Wellington, K. W. (2015) · RSC Advances · doi:10.1039/c4ra13547d · Cited by 316
Antonenko, Y. N., Avetisyan, A. V., Bakeeva, L. E., Chernyak, B. V., Chertkov, V. A., Domnina, L. V., Ivanova, O. Y., Izyumov, D. S., Khailova, L. S., Klishin, S. S., et al. (2008) · Biochemistry (Moscow) · doi:10.1134/s0006297908120018 · Cited by 326
Kong, A.-N. T., Owuor, E., Yu, R., Hebbar, V., Chen, C., Hu, R., & Mandlekar, S. (2001) · Drug Metabolism Reviews · doi:10.1081/dmr-120000652 · Cited by 316
PCBs: Recent Advances in Environmental Toxicology and Health Effects
Robertson, L. W., & Hansen, L. G. (2015) · Project Muse (Johns Hopkins University) · Cited by 333
Iyanagi, T. (2007) · International Review of Cytology · doi:10.1016/s0074-7696(06)60002-8 · Cited by 290
Development of a Microscale Cell Culture Analog To Probe Naphthalene Toxicity
Viravaidya, K., Sin, A., & Shuler, M. L. (2008) · Biotechnology Progress · doi:10.1021/bp0341996 · Cited by 305
Diverse immune functions of hemocyanins
Coates, C. J., & Nairn, J. (2014) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2014.01.021 · Cited by 299
Duran, R., & Cravo-Laureau, C. (2016) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuw031 · Cited by 294
Bonvallot, V., Baeza-Squiban, A., Baulig, A., Brulant, S., Boland, S., Muzeau, F., Barouki, R., & Marano, F. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.25.4.4515 · Cited by 289
Atmospheric Reactions Influence Seasonal PAH and Nitro-PAH Concentrations in the Los Angeles Basin
Reisen, F., & Arey, J. (2005) · Environmental Science & Technology · doi:10.1021/es035454l · Cited by 281
Kim, S.-J., Kweon, O., Jones, R. C., Freeman, J. P., Edmondson, R. D., & Cerniglia, C. E. (2007) · Journal of Bacteriology · doi:10.1128/jb.01310-06 · Cited by 279
Molecular mechanisms of arsenic carcinogenesis
Huang, C., Ke, Q., Costa, M., & Shi, X. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000007261.04684.78 · Cited by 288
On the history of oxidative stress: Concept and some aspects of current development
Sies, H. (2018) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2018.01.002 · Cited by 285
Interactions by carcinogenic metal compounds with DNA repair processes: toxicological implications
Hartwig, A., & Schwerdtle, T. (2002) · Toxicology Letters · doi:10.1016/s0378-4274(01)00482-9 · Cited by 278
Flavonoids and alkenylbenzenes: Mechanisms of mutagenic action and carcinogenic risk
Rietjens, I. M. C. M., Boersma, M. G., van der Woude, H., Jeurissen, S. M. F., Schutte, M. E., & Alink, G. M. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2005.01.028 · Cited by 281
Kang, K. W., Lee, S. J., Park, J. W., & Kim, S. G. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.1001 · Cited by 274
Kostadinova, R., Boess, F., Applegate, D., Suter, L., Weiser, T., Singer, T., Naughton, B., & Roth, A. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.01.012 · Cited by 262
Bull, R. J., Reckhow, D. A., Li, X., Humpage, A. R., Joll, C., & Hrudey, S. E. (2011) · Toxicology · doi:10.1016/j.tox.2011.05.004 · Cited by 255
Gu, M., & Imlay, J. A. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07520.x · Cited by 251
Cho, A. K., Di Stefano, E., You, Y., Rodriguez, C. E., Schmitz, D. A., Kumagai, Y., Miguel, A. H., Eiguren-Fernandez, A., Kobayashi, T., Avol, E., et al. (2004) · Aerosol Science and Technology · doi:10.1080/02786820390229471 · Cited by 241
Ishii, T., Mori, T., Tanaka, T., Mizuno, D., Yamaji, R., Kumazawa, S., Nakayama, T., & Akagawa, M. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.07.023 · Cited by 242
Respiratory protein–generated reactive oxygen species as an antimicrobial strategy
Jiang, N., Tan, N. S., Ho, B., & Ding, J. L. (2007) · Nature Immunology · doi:10.1038/ni1501 · Cited by 243
Potential Mechanisms of Estrogen Quinone Carcinogenesis
Bolton, J. L., & Thatcher, G. R. J. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700191p · Cited by 241
Self-citationCrystal Structure of Quinone Reductase 2 in Complex with Resveratrol,
Buryanovskyy, L., Fu, Y., Boyd, M., Ma, Y., Hsieh, T.-C., Wu, J. M., & Zhang, Z. (2004) · Biochemistry · doi:10.1021/bi049162o · Cited by 236
Valavanidis, A., Fiotakis, K., Bakeas, E., & Vlahogianni, T. (2005) · Redox Report · doi:10.1179/135100005x21606 · Cited by 233
Causes of genome instability: the effect of low dose chemical exposures in modern society
Langie, S. A. S., Koppen, G., Desaulniers, D., Al-Mulla, F., Al-Temaimi, R., Amedei, A., Azqueta, A., Bisson, W. H., Brown, D., Brunborg, G., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv031 · Cited by 209
Oxidative conjugation of catechols with proteins in insect skeletal systems
Kramer, K. J., Kanost, M. R., Hopkins, T. L., Jiang, H., Zhu, Y. C., Xu, R., Kerwin, J. L., & Turecek, F. (2001) · Tetrahedron · doi:10.1016/s0040-4020(00)00949-2 · Cited by 229
The Trypanocidal Activity of Naphthoquinones: A Review
Ventura Pinto, A., & Lisboa de Castro, S. (2009) · Molecules · doi:10.3390/molecules14114570 · Cited by 219
Wassenberg, D. M., & Di Giulio, R. T. (2004) · Environmental Health Perspectives · doi:10.1289/ehp.7168 · Cited by 213
Structure–activity relationships for inhibition of human 5α-reductases by polyphenols
Hiipakka, R. A., Zhang, H.-Z., Dai, W., Dai, Q., & Liao, S. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00848-1 · Cited by 216
Comparative developmental toxicity of environmentally relevant oxygenated PAHs
Knecht, A. L., Goodale, B. C., Truong, L., Simonich, M. T., Swanson, A. J., Matzke, M. M., Anderson, K. A., Waters, K. M., & Tanguay, R. L. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.05.006 · Cited by 208
Andrés, C. M. C., Pérez de la Lastra, J. M., Juan, C. A., Plou, F. J., & Pérez-Lebeña, E. (2023) · Processes · doi:10.3390/pr11092771 · Cited by 187
Hillard, E. A., de Abreu, F. C., Ferreira, D. C. M., Jaouen, G., Goulart, M. O. F., & Amatore, C. (2008) · Chemical Communications · doi:10.1039/b718116g · Cited by 216
DECABROMODIPHENYL ETHER IN THE RAT: ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION
Mörck, A., Hakk, H., Örn, U., & Wehler, E. K. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.7.900 · Cited by 206
Predicting Fish Acute Toxicity Using a Fish Gill Cell Line-Based Toxicity Assay
Tanneberger, K., Knöbel, M., Busser, F. J. M., Sinnige, T. L., Hermens, J. L. M., & Schirmer, K. (2013) · Environmental Science & Technology · doi:10.1021/es303505z · Cited by 202
Effects of pH on the degradation of phenanthrene and pyrene by Mycobacterium vanbaalenii PYR-1
Kim, Y.-H., Freeman, J. P., Moody, J. D., Engesser, K.-H., & Cerniglia, C. E. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-004-1796-y · Cited by 201
Mechanisms of Troglitazone Hepatotoxicity
Smith, M. T. (2003) · Chemical Research in Toxicology · doi:10.1021/tx034033e · Cited by 197
Behera, B. K., Das, A., Sarkar, D. J., Weerathunge, P., Parida, P. K., Das, B. K., Thavamani, P., Ramanathan, R., & Bansal, V. (2018) · Environmental Pollution · doi:10.1016/j.envpol.2018.05.016 · Cited by 193
Firenzuoli, F., Gori, L., & di Sarsina, P. R. (2011) · Evidence-Based Complementary and Alternative Medicine · doi:10.1093/ecam/nen009 · Cited by 187
Sajiki, J., & Yonekubo, J. (2003) · Chemosphere · doi:10.1016/s0045-6535(02)00789-0 · Cited by 181
Wang, X., Thomas, B., Sachdeva, R., Arterburn, L., Frye, L., Hatcher, P. G., Cornwell, D. G., & Ma, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510962103 · Cited by 186
Burdick, A. D., Davis, J. W., Liu, K. J., Hudson, L. G., Shi, H., Monske, M., & Burchiel, S. W. (2003) · PubMed · Cited by 217
Viravaidya, K., & Shuler, M. L. (2004) · Biotechnology Progress · doi:10.1021/bp034238d · Cited by 184
Widhalm, J. R., & Rhodes, D. (2016) · Horticulture Research · doi:10.1038/hortres.2016.46 · Cited by 173
Development of Novel Antioxidants: Design, Synthesis, and Reactivity
Hussain, H. H., Babic, G., Durst, T., Wright, J. S., Flueraru, M., Chichirau, A., & Chepelev, L. L. (2003) · The Journal of Organic Chemistry · doi:10.1021/jo0301090 · Cited by 180
Ding, J., Zhong, J., Yang, Y., Li, B., Shen, G., Su, Y., Wang, C., Li, W., Shen, H., Wang, B., et al. (2012) · Environmental Pollution · doi:10.1016/j.envpol.2011.10.008 · Cited by 176
Keyte, I. J., Albinet, A., & Harrison, R. M. (2016) · Science of The Total Environment · doi:10.1016/j.scitotenv.2016.05.152 · Cited by 176
Cancer: Thymoquinone antioxidant/pro-oxidant effect as potential anticancer remedy
Mahmoud, Y. K., & Abdelrazek, H. M. A. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108783 · Cited by 174
The Biochemistry of Drug Metabolism – An Introduction: Part 2. Redox Reactions and Their Enzymes
Testa, B., & Krämer, S. D. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790032 · Cited by 171
Higgins, L. G., Kelleher, M. O., Eggleston, I. M., Itoh, K., Yamamoto, M., & Hayes, J. D. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.03.005 · Cited by 177
Deleterious Effects of Reactive Metabolites
Attia, S. M. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.4.13246 · Cited by 174
Li, J., Wang, W., Moe, B., Wang, H., & Li, X.-F. (2015) · Chemical Research in Toxicology · doi:10.1021/tx500494r · Cited by 173
Positive and negative effects of polyphenol incorporation in baked foods
Ou, J., Wang, M., Zheng, J., & Ou, S. (2019) · Food Chemistry · doi:10.1016/j.foodchem.2019.01.096 · Cited by 163
Soares, A. R., Marchiosi, R., Siqueira-Soares, R. D. C., Barbosa de Lima, R., Dantas dos Santos, W., & Ferrarese-Filho, O. (2014) · Plant Signaling & Behavior · doi:10.4161/psb.28275 · Cited by 161
Saito, Y., Nishio, K., Ogawa, Y., Kinumi, T., Yoshida, Y., Masuo, Y., & Niki, E. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.12.004 · Cited by 170
United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity
Mahady, G. B., Dog, T. L., Barrett, M. L., Chavez, M. L., Gardiner, P., Ko, R., Marles, R. J., Pellicore, L. S., Giancaspro, G. I., & Sarma, D. N. (2008) · Menopause · doi:10.1097/gme.0b013e31816054bf · Cited by 169
Kim, S., Ko, H., Park, J. E., Jung, S., Lee, S. K., & Chun, Y.-J. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010298j · Cited by 168
Brandt, G. E. L., Schmidt, M. D., Prisinzano, T. E., & Blagg, B. S. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8007486 · Cited by 166
A Toxic Disinfection By‐product, 2,6‐Dichloro‐1,4‐benzoquinone, Identified in Drinking Water
Qin, F., Zhao, Y., Zhao, Y., Boyd, J. M., Zhou, W., & Li, X. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200904934 · Cited by 167
A comparative study of oxidative DNA damage in mammalian spermatozoa
Bennetts, L. E., & Aitken, R. J. (2005) · Molecular Reproduction and Development · doi:10.1002/mrd.20285 · Cited by 163
Benzo(a)pyrene‐induced acute neurotoxicity in the F‐344 rat: role of oxidative stress
Saunders, C. R., Das, S. K., Ramesh, A., Shockley, D. C., & Mukherjee, S. (2006) · Journal of Applied Toxicology · doi:10.1002/jat.1157 · Cited by 164
A Plant Defense Response Effector Induces Microbial Apoptosis
Narasimhan, M. L., Damsz, B., Coca, M. A., Ibeas, J. I., Yun, D.-J., Pardo, J. M., Hasegawa, P. M., & Bressan, R. A. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00365-3 · Cited by 166
Juglone-induced apoptosis in human gastric cancer SGC-7901 cells via the mitochondrial pathway
Ji, Y.-B., Qu, Z.-Y., & Zou, X. (2011) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2009.09.010 · Cited by 164
Mossa, A.-T. H., Swelam, E. S., & Mohafrash, S. M. M. (2015) · Toxicology Reports · doi:10.1016/j.toxrep.2015.02.009 · Cited by 182
Pyrroloquinoline-quinone and its versatile roles in biological processes
Misra, H. S., Rajpurohit, Y. S., & Khairnar, N. P. (2012) · Journal of Biosciences · doi:10.1007/s12038-012-9195-5 · Cited by 161
Metadata
- Authors
- Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., & Monks, T. J.
- Affiliations
- Johns Hopkins University (US)
- Venue
- Chemical Research in Toxicology
- Publisher
- American Chemical Society (ACS)
- Published
- 2000-02-23
- Volume
- 13
- Issue
- 3
- Pages
- 135-160
- ISSN
- 0893-228X (ISSN-L)
- 1520-5010
- OpenAlex
- W2090990681
- Cited by
- 1,703
- References
- 96
- Citations by year
- 2026: 61 · 2025: 55 · 2024: 51 · 2023: 66 · 2022: 65 · 2021: 82 · 2020: 68 · 2019: 76 · 2018: 71 · 2017: 63 · 2016: 75 · 2015: 80 · 2014: 89 · 2013: 79 · 2012: 78
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chemical Research in Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01es003760-16)
- National Cancer Institute (CA73638)
- National Institute of Environmental Health Sciences (ES03760, ES03819, P30ES003819)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- quinones, quinone toxicity, Michael acceptors, alkylation, redox cycling, semiquinone, reactive oxygen species, oxidative stress, 8-hydroxy-2'-deoxyguanosine, carcinogenesis, immunotoxicity, cytotoxicity, benzene, polycyclic aromatic hydrocarbons, estrogen metabolites, catecholamines, protein kinase C, Ras signaling
- MeSH terms
- Alkylation, Animals, Benzene, Catecholamines, Estrogens, Humans, Polycyclic Aromatic Hydrocarbons, Quinones, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.